The corporate selected is having status as amalgamated hence financial data is not available. You may check its last filed documents by making a request.
About
Basic Data Updated:
4 months agoIndustry
Company Details
- Location
Thane, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U24230MH2008PTC271062 |
Company No. | 271062 |
Company Classification | Private Limited Indian Non-Government Company |
Incorporation Date | 04 Sep 2008 |
Date of AGM | 15 Sep 2020 |
Date of Balance Sheet | 31 Mar 2020 |
Listing Status | Unlisted |
ROC Code | Roc Mumbai |
Financials of Fagris Medica Private Limieted
Fagris Medica Private Limieted, for the financial year ended 2019, experienced significant reduction in revenue, with a 92.32% decrease. The company also saw a substantial improvement in profitability, with a 783.56% increase in profit. The company's net worth Soared by an impressive increase of 34.53%.
Corporate Structure
Unlock access to Fagris Medica Limieted's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Fagris Medica Private Limieted
Unlock and access historical data on people associated with Fagris Medica Limieted, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
The Federal Bank Limited Creation Date: 17 Sep 2009 | ₹9.00 M | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fagris Medica Limieted, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fagris Medica Limieted's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Recent activity within the organization
Annual General Meeting
Fagris Medica Private Limieted last Annual general meeting of members was held on 15 Sep 2020 as per latest MCA records.
15 Sep 2020Balance Sheet
Fagris Medica Private Limieted has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai.
31 Mar 2020Director Appointment
Sormistha Ghosh was appointed as a Director was appointed as a Director on 25 Oct 2019 & has been associated with this company since 4 years 10 months .
25 Oct 2019Director Appointment
Krishnan Tirucherai Parthasarathy was appointed as a Director was appointed as a Director on 30 Jan 2018 & has been associated with this company since 6 years 7 months .
30 Jan 2018Charges
A charge registered on 17 Sep 2009 via Charge ID 10177039 with The Federal Bank Limited was fully satisfied on 24 Apr 2012.
24 Apr 2012
Recent News, Updates & Announcement
- Strides Pharma gains after arm receives USFDA nod for Pregabalin capsule.
Moneycontrol 29 Jan 2024
- CMS00867 Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA.
SHENZHEN CHINA Jan 02 2024 GLOBE NEWSWIRE On 29 December 2023 PharmaGend Global Medical Services Pte Ltd PharmaGend jointly invested.
China Medical System Holdings Ltd 02 Jan 2024
- Strides arm and its partner get USFDA nod for hypokalemia treatment drug.
The approved product used in treatment of patients with hypokalemia is a generic version of Merck Incs Potassium Chloride extendedrelease tablets a regulatory filing said.
Economic Times 02 Apr 2019
- Strides subsidiary inks pact with SUDA Pharmaceuticals for migraine drug.
Expressbpd 09 Nov 2018
- Strides Pharma Science to get USD 20 mn funding for consumer healthcare business.
Drug firm Strides Pharma Science Wednesday said it has partnered with funds advised by ICPIII Investment Advisors which will infuse USD 20 million into its consumer healthcare business.
PTI 31 Oct 2018
Frequently asked questions
What is the Incorporation or founding date of Fagris Medica Private Limieted?